颈椎间盘假体的临床相关性:两项随机对照试验的临床结果合并分析
该研究回顾性分析了两项随机双盲试验中251例单节段椎间盘突出患者的数据,比较颈椎前路椎间盘切除加关节成形术(ACDA)与融合术(ACDF)或单纯椎间盘切除术(ACD)的临床结果。术后2年,ACDA在NDI等指标上未显示出优于ACDF或ACD的临床获益,亚组分析也未发现任何亚组更能从某种手术中获益。
要点
- ACDA术后2年NDI改善与ACDF或ACD相当,差异未超过20分的最小临床重要差异(MCID)。
- 次要结局指标在各治疗组间结果相当。
- 初步亚组分析未发现年龄、椎间盘高度、BMI、吸烟或性别亚组间存在临床相关差异。
核心结论
- 合并两项随机对照试验数据后,ACDA与ACDF或ACD相比在术后2年无临床获益。
- 初步亚组分析未发现任何亚组更能从ACD、ACDF或ACDA中获益。
研究设计与样本
- 回顾性分析两项随机双盲临床试验的数据,共纳入251例单节段椎间盘突出患者。
- 比较ACDA与ACDF及无内固定的ACD的临床结果。
主要发现
- 所有治疗组NDI均下降至基线值约50%,边际平均NDI差异在100分量表上为0.4至1.1,置信区间从未超过20分的MCID。
- 次要结局参数显示各组结果相当。
- 术后2年初步亚组分析未能证明治疗间NDI存在临床相关差异。
关键数值与推荐
- NDI边际平均差异范围0.4至1.1(100分制),置信区间未超过20分MCID。
- 证据等级为1级。
临床怎么用
- 对于单节段椎间盘突出,ACDA在术后2年未显示优于ACDF或ACD的临床结果,选择术式时可综合考虑其他因素。
- 亚组分析未识别出可从特定术式中更多获益的患者群体。
局限性
- 原文未报告
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY DESIGN: Retrospective analysis was performed on data from 251 patients that were included in two randomized, double-blinded clinical trials comparing clinical results of anterior cervical discectomy and arthroplasty (ACDA) to anterior cervical discectomy and fusion (ACDF), and anterior cervical discectomy (ACD), for single-level disc herniation. OBJECTIVE: This study aimed to investigate whether the ACDA procedure offers superior clinical results 2 years after surgery, to either ACDF or ACD without instrumentation, in the entire group of patients or in a particular subgroup of patients. SUMMARY OF BACKGROUND DATA: The cervical disc prosthesis was introduced to provide superior clinical outcomes after ACD. METHODS: Neck Disability Index (NDI), and subscales of the 36-item short-form health survey (SF-36) and McGill pain score were collected at baseline, 1 year and 2 years after surgery. Reoperations and complications were also evaluated. A preliminary subgroup analysis was performed for age, disc height, body mass index (BMI), smoking, and sex. RESULTS: The NDI decreased comparably in all treatment arms to circa 50% of the baseline value and marginal mean NDI differences varied from 0.4 to 1.1 on a 100 point NDI scale, with confidence intervals never exceeding the 20-point minimal clinical important difference (MCID). Secondary outcome parameters showed comparable results. Preliminary subgroup analysis could not demonstrate clinically relevant differences in NDI between treatments after 2 years. CONCLUSION: After combining data from two Randomized Controlled Trials it can be concluded that there is no clinical benefit for ACDA, when compared with ACDF or ACD 2 years after surgery. Preliminary subgroup analysis indicated outcomes were similar between treatment groups, and that no subgroup could be appointed that benefited more from either ACD, ACDF, or ACDA.Level of Evidence: 1.
引用
- Goedmakers CMW, Bartels RHMA, Donk RD, et al. The Clinical Relevance of the Cervical Disc Prosthesis: Combining Clinical Results of Two RCTs. Spine (Phila Pa 1976). 2022. PMID: 34474447. doi:10.1097/BRS.0000000000004113
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。